CNS chemokines, cytokines, and dendritic cells in autoimmune demyelination

Journal of the Neurological Sciences

Volumn 228, Issue 2, 2005, Pages 210-214

  Segal, Benjamin M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; PROTEOLIPID PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONFERENCE PAPER; DEMYELINATING DISEASE; DENDRITIC CELL; EOSINOPHIL; HELMINTHIASIS; HISTOPATHOLOGY; HUMAN; LEUKOCYTE; NEUROIMMUNOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE INJURY;

EID: 13444261147     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.10.014     Document Type: Conference Paper

References (67)

1. R. Martin, H.F. McFarland, and D.E. McFarlin Immunological aspects of demyelinating diseases Annu. Rev. Immunol. 10 1992 153 187
2. F. Mokhtarian, D.E. McFarlin, and C.S. Raine Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice Nature 309 1984 356 358
3. S.S. Zamvil, and L. Steinman The T lymphocyte in experimental allergic encephalomyelitis Annu. Rev. Immunol. 8 1990 579 621
4. D.S. Linthicum, and J.A. Frelinger Acute autoimmune encephalomyelitis in mice. II: Susceptibility is controlled by the combination of H-2 and histamine sensitization genes J. Exp. Med. 156 1982 31 40
5. P. Rao, and B.M. Segal Experimental autoimmune encephalomyelitis Methods Mol. Med. 102 2004 363 376
6. C.B. Pettinelli, and D.E. McFarlin Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes J. Immunol. 127 1981 1420 1423
7. V.K. Kuchroo, R.A. Sobel, T. Yamamura, E. Greenfield, M.E. Dorf, and M.B. Lees Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides Pathobiology 59 1991 305 312
8. S. Zamvil, P. Nelson, J. Trotter, D. Mitchell, R. Knobler, and R. Fritz T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination Nature 317 1985 355 358
9. M.K. Waldor, S. Sriram, R. Hardy, L.A. Herzenberg, L.A. Herzenberg, and L. Lanier Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker Science 227 1985 415 417
10. D. Cohen, O. Cohen, A. Marcadet, C. Massart, M. Lathrop, and I. Deschamps Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis Proc. Natl. Acad. Sci. U. S. A. 81 1984 1774 1778
11. B. Bielekova, B. Goodwin, N. Richert, I. Cortese, T. Kondo, and G. Afshar Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand Nat. Med. 6 2000 1167 1175
12. T.R. Mosmann, and R.L. Coffman TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties Annu. Rev. Immunol. 7 1989 145 173
13. D.J. Cua, D.R. Hinton, and S.A. Stohlman Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease J. Immunol. 155 1995 4052 4059
14. A. Khoruts, S.D. Miller, and M.K. Jenkins Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells J. Immunol. 155 1995 5011 5017
15. M.B. Powell, D. Mitchell, J. Lederman, J. Buckmeier, S.S. Zamvil, and M. Graham Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity Int. Immunol. 2 1990 539 544
16. D.G. Ando, J. Clayton, D. Kono, J.L. Urban, and E.E. Sercarz Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype Cell. Immunol. 124 1989 132 143
17. S. Issazadeh, J.C. Lorentzen, M.I. Mustafa, B. Hojeberg, A. Mussener, and T. Olsson Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta J. Neuroimmunol. 69 1996 103 115
18. M.K. Kennedy, D.S. Torrance, K.S. Picha, and K.M. Mohler Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery J. Immunol. 149 1992 2496 2505
19. A. Windhagen, J. Newcombe, F. Dangond, C. Strand, M.N. Woodroofe, and M.L. Cuzner Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions J. Exp. Med. 182 1995 1985 1996
20. C.D. Rohowsky-Kochan, D. Molinaro, and S.D. Cook Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis Mult. Scler. 6 2000 69 77
21. F.D. Lublin, R.L. Knobler, B. Kalman, M. Goldhaber, J. Marini, and M. Perrault Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis Autoimmunity 16 1993 267 274
22. H. Heremans, C. Dillen, M. Groenen, E. Martens, and A. Billiau Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma Eur. J. Immunol. 26 1996 2393 2398
23. T.T. Duong, J. St. Louis, J.J. Gilbert, F.D. Finkelman, and G.H. Strejan Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse J. Neuroimmunol. 36 1992 105 115
24. T.T. Duong, F.D. Finkelman, B. Singh, and G.H. Strejan Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains J. Neuroimmunol. 53 1994 101 107
25. I.A. Ferber, S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, and L. Steinman Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE) J. Immunol. 156 1996 5 7
26. M. Krakowski, and T. Owens Interferon-gamma confers resistance to experimental allergic encephalomyelitis Eur. J. Immunol. 26 1996 1641 1646
27. B.M. Segal, B.K. Dwyer, and E.M. Shevach An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease J. Exp. Med. 187 1998 537 546
28. D.O. Willenborg, S. Fordham, C.C. Bernard, W.B. Cowden, and I.A. Ramshaw IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis J. Immunol. 157 1996 3223 3227
29. D. Sean Riminton, H. Korner, D.H. Strickland, F.A. Lemckert, J.D. Pollard, and J.D. Sedgwick Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice J. Exp. Med. 187 1998 1517 1528
30. J. Liu, M.W. Marino, G. Wong, D. Grail, A. Dunn, and J. Bettadapura TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination Nat. Med. 4 1998 78 83
31. K. Frei, H.P. Eugster, M. Bopst, C.S. Constantinescu, E. Lavi, and A. Fontana Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis J. Exp. Med. 185 1997 2177 2182
32. G. Trinchieri Interleukin-12 and the regulation of innate resistance and adaptive immunity Nat. Rev., Immunol. 3 2003 133 146
33. C. Parham, M. Chirica, J. Timans, E. Vaisberg, M. Travis, and J. Cheung A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R J. Immunol. 168 2002 5699 5708
34. B. Becher, B.G. Durell, and R.J. Noelle Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 J. Clin. Invest. 110 2002 493 497
35. D.J. Cua, J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, and B. Seymour Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 2003 744 748
36. C.S. Constantinescu, M. Wysocka, B. Hilliard, E.S. Ventura, E. Lavi, and G. Trinchieri Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis J. Immunol. 161 1998 5097 5104
37. J.P. Leonard, K.E. Waldburger, and S.J. Goldman Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12 J. Exp. Med. 181 1995 381 386
38. L.V. Bagaeva, L.P. Williams, and B.M. Segal IL-12 dependent/IFN gamma independent expression of CCR5 by myelin-reactive T cells correlates with encephalitogenicity J. Neuroimmunol. 137 2003 109 116
39. B.M. Segal, and E.M. Shevach IL-12 unmasks latent autoimmune disease in resistant mice J. Exp. Med. 184 1996 771 775
40. B.M. Segal, D.M. Klinman, and E.M. Shevach Microbial products induce autoimmune disease by an IL-12-dependent pathway J. Immunol. 158 1997 5087 5090
41. B.M. Segal, J.T. Chang, and E.M. Shevach CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo J. Immunol. 164 2000 5683 5688
42. J.T. Chang, E.M. Shevach, and B.M. Segal Regulation of interleukin (IL)-12 receptor beta2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cells J. Exp. Med. 189 1999 969 978
43. F. Nicoletti, F. Patti, C. Cocuzza, P. Zaccone, A. Nicoletti, and R. Di Marco Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis J. Neuroimmunol. 70 1996 87 90
44. K.E. Balashov, D.R. Smith, S.J. Khoury, D.A. Hafler, and H.L. Weiner Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand Proc. Natl. Acad. Sci. U. S. A. 94 1997 599 603
45. M. Comabella, K. Balashov, S. Issazadeh, D. Smith, H.L. Weiner, and S.J. Khoury Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy J. Clin. Invest. 102 1998 671 678
46. A.H. van Boxel-Dezaire, S.C. Hoff, B.W. van Oosten, C.L. Verweij, A.M. Drager, and H.J. Ader Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis Ann. Neurol. 45 1999 695 703
47. K. Fassbender, A. Ragoschke, S. Rossol, A. Schwartz, O. Mielke, and A. Paulig Increased release of interleukin-12p40 in MS: association with intracerebral inflammation Neurology 51 1998 753 758
48. N. Kawakami, S. Lassmann, Z. Li, F. Odoardi, T. Ritter, and T. Ziemssen The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis J. Exp. Med. 199 2004 185 197
49. A.H. Cross, B. Cannella, C.F. Brosnan, and C.S. Raine Homing to central nervous system vasculature by antigen-specific lymphocytes. I: Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis Lab. Invest. 63 1990 162 170
50. W.J. Karpus, N.W. Lukacs, B.L. McRae, R.M. Strieter, S.L. Kunkel, and S.D. Miller An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis J. Immunol. 155 1995 5003 5010
51. W.J. Karpus, and K.J. Kennedy MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation J. Leukoc. Biol. 62 1997 681 687
52. W.J. Karpus, and R.M. Ransohoff Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis J. Immunol. 161 1998 2667 2671
53. W.J. Karpus, K.J. Kennedy, B.T. Fife, and L.M. Hoffman Chemokine regulation of immune-mediated demyelinating disease ILAR J. 40 1999 183 189
54. B.T. Fife, G.B. Huffnagle, W.A. Kuziel, and W.J. Karpus CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis J. Exp. Med. 192 2000 899 905
55. L.A. Boven, L. Montagne, H.S. Nottet, and C.J. De Groot Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions Clin. Exp. Immunol. 122 2000 257 263
56. T.L. Sorensen, M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, and V.A. Folcik Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients J. Clin. Invest. 103 1999 807 815
57. C. Trebst, T.L. Sorensen, P. Kivisakk, M.K. Cathcart, J. Hesselgesser, and R. Horuk CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis Am. J. Pathol. 159 2001 1701 1710
58. T.L. Sorensen, C. Trebst, P. Kivisakk, K.L. Klaege, A. Majmudar, and R. Ravid Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system J. Neuroimmunol. 127 2002 59 68
59. J.E. Simpson, J. Newcombe, M.L. Cuzner, and M.N. Woodroofe Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions Neuropathol. Appl. Neurobiol. 26 2000 133 142
60. B.T. Fife, K.J. Kennedy, M.C. Paniagua, N.W. Lukacs, S.L. Kunkel, and A.D. Luster CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis J. Immunol. 166 2001 7617 7624
61. K.E. Balashov, J.B. Rottman, H.L. Weiner, and W.W. Hancock CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions Proc. Natl. Acad. Sci. U. S. A. 96 1999 6873 6878
62. J.G. Cyster Chemokines and cell migration in secondary lymphoid organs Science 286 1999 2098 2102
63. C. Alt, M. Laschinger, and B. Engelhardt Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis Eur. J. Immunol. 32 2002 2133 2144
64. S. Columba-Cabezas, B. Serafini, E. Ambrosini, and F. Aloisi Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation Brain Pathol. 13 2003 38 51
65. R. Magliozzi, S. Columba-Cabezas, B. Serafini, and F. Aloisi Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis J. Neuroimmunol. 148 2004 11 23
66. M. Pashenkov, M. Soderstrom, and H. Link Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation J. Neuroimmunol. 135 2003 154 160
67. B. Serafini, B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis Brain Pathol. 14 2004 164 174